Panacea Acquisition Stock Quote NUVB - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

3.11

Bid

Ask

Volume

1,956,197

3.15 Day's Range 3.305

0.95 52 Week Range 4.1598

Market Cap

716.281M

Previous Close

3.20

Open

3.28

Last Trade

155

3.11

(formt)

Last Trade Time

Financial Volume

$ 6,371,177

VWAP

3.2569

Average Volume (3m)

1,452,001

Shares Outstanding

219,046,219

Dividend Yield

PE Ratio

-9.45

Earnings Per Share (EPS)

-0.35

Revenue

Net Profit

-75.8M

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

ecor1cap.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker NUVB. The last closing price for Panacea Acquisition was $3.20. Over the last year, Panacea Acquisition shares have traded in a share price range of $ 0.95 to $ 4.1598.

Panacea Acquisition currently has 219,046,219 shares outstanding. The market capitalization of Panacea Acquisition is $716.28 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -9.45.

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.47	17.803030303	2.64	3.305	2.525	1214860	2.9680606	CS
4	-0.59	-15.9459459459	3.7	3.865	2.505	1261004	2.97412496	CS
12	1.44	86.2275449102	1.67	4.1598	1.645	1452001	2.85962635	CS
26	1.94	165.811965812	1.17	4.1598	1.17	1159516	2.2572478	CS
52	1.49	91.975308642	1.62	4.1598	0.95	978870	1.89587611	CS
156	-8.03	-72.0825852783	11.14	15.23	0.95	879467	4.26480716	CS
260	-6.89	-68.9	10	15.23	0.95	884100	4.83123641	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUVOHoldco Nuvo Group DG Ltd	4.71 (2,040.91%)	106.68k
XBPXBP Europe Holdings Inc	$ 2.20 (67.94%)	18.82M
NUWENewellis Inc	$ 0.2101 (57.97%)	72.29M
VWEVintage Wine Estates Inc	$ 0.36 (55.17%)	790.52k
ENVXEnovix Corporation	$ 9.50 (45.93%)	25.83M
XPELXPEL Inc	$ 32.84 (-38.95%)	2.29M
PLTNPlutoniam Acquisition Corporation	$ 6.35 (-30.60%)	104.83k
ARAYAccuray Incorporated	$ 1.535 (-29.26%)	5.31M
BONBon Natural Life Ltd	$ 2.75 (-28.57%)	729.3k
HSDTHelius Medical Technologies Inc	$ 2.65 (-26.39%)	197.13k
JAGXJaguar Health Inc	$ 0.2932 (30.31%)	184.28M
SQQQProShares UltraPro Short QQQ	$ 11.78 (-3.60%)	141.24M
FFIEFaraday Future Intelligent Electric Inc	$ 0.0402 (-12.80%)	116.5M
AAPLApple Inc	$ 173.03 (2.20%)	95.38M
ALLRAllarity Therapeutics Inc	$ 1.1901 (-13.13%)	94.38M